Technological Innovations in Behavioral Treatments for Cigarette Smoking
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 96
- 试验地点
- 2
- 主要终点
- CO sample of ≤ 4ppm
研究概览
简要总结
The purpose of the study is to evaluate a sustainable and broadly accessible treatment delivery model (Motiv8) for smoking cessation based on abstinence-reinforcement.
详细描述
Smokers are randomly assigned to one of two groups: an Abstinence Contingent (AC) group and a Submission Contingent (SC) group. The AC group receives vouchers for abstaining from smoking (measured by a carbon monoxide monitor and confirmed through video-submission), and the SC group receives vouchers for submitting videos of their carbon monoxide breath tests. Both groups take videos of their CO-monitoring on a secure website designed for the study, as well as receive standard care counseling and education related to smoking cessation. The main intervention lasts four weeks, and a three-week maintenance phase will follow. Assessments will be conducted at intake, week four (end of the main treatment phase), and at three and six months after the intervention period is completed
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Care Provider)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Self-reported smoker
- •Permission to contact applicant by phone
- •Ability to use the internet
排除标准
- •Self-report of a history of or current severe or unstable medical or psychiatric illness that would interfere with the study
结局指标
主要结局
CO sample of ≤ 4ppm
时间窗: 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention
Participant reporting not smoking, not even a puff in the last 7 days.
时间窗: 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention
次要结局
- Twice-daily breath CO samples obtained during treatment period.(First 4 weeks of treatment)
- The longest duration of sustained abstinence based on the twice-daily breath samples during the treatment period.(First 4 weeks of treatment)
研究者
Jesse Dallery
Principal Investigator
National Development and Research Institutes, Inc.